South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2024-2032

South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A15993
Buy Now

Market Overview:

South Korea diabetes drugs market size is projected to exhibit a growth rate (CAGR) of 3.51% during 2024-2032. The rising prevalence of diabetes, increasing adoption of advanced technologies and telemedicine, and the expansion of hospitals, clinics, and other healthcare facilities in the country represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 3.51%


Diabetes drugs are used to manage and regulate blood glucose levels among individuals with diabetes. They encompass a range of mechanisms, including insulin secretion, insulin resistance reduction, and glucose absorption inhibition. They are available in different classes, such as sulfonylureas, biguanides, DPP-4 inhibitors, SGLT-2 inhibitors, and GLP-1 receptor agonists. They require a prescription from a healthcare provider due to their potential side effects and individualized treatment plans. They help individuals maintain stable blood glucose levels, preventing hyperglycemia and hypoglycemia. Diabetes drugs enhance the sensitivity of the body to insulin, enabling cells to utilize glucose better. Besides this, they reduce the risk of diabetes-related complications like cardiovascular disease, kidney problems, and neuropathy. They contribute to a better quality of life by minimizing symptoms, such as excessive thirst, frequent urination, and fatigue. They are prescribed alongside dietary changes and physical activity to achieve optimal blood sugar control. They are used to prevent or delay the progression of prediabetes to full-blown diabetes.

South Korea Diabetes Drugs Market Trends:

The rising prevalence of type 2 diabetes due to sedentary lifestyles, changing dietary habits, and an aging population represents one of the key factors catalyzing the demand for effective pharmaceutical interventions in South Korea. Along with this, physicians are increasingly prescribing combination medications that target multiple facets of diabetes management, such as glucose control, insulin sensitivity, and weight management, which is strengthening the growth of the market in the country. Additionally, pharmaceutical companies are developing and marketing combination drugs that offer comprehensive solutions, addressing multiple aspects of diabetes in a single medication. Apart from this, the rising adoption of advanced technologies and telemedicine is streamlining patient care and management. The integration of digital platforms and digital health into diabetes management is facilitating remote monitoring of the glucose levels of patients. These technological advancements are enhancing patient outcomes and fueling the market growth by creating new avenues for pharmaceutical companies to introduce innovative diabetes drugs. Furthermore, governing authorities of the country are focusing on improving healthcare accessibility and affordability, which is offering a favorable market outlook. They are implementing universal healthcare coverage and emphasizing preventive healthcare measures to make diabetes diagnosis and treatment more accessible to a broader segment of the population. Moreover, the introduction of once-daily oral medications and user-friendly insulin delivery devices is improving patient compliance and reducing the burden of frequent injections. These advancements are enhancing the quality of life for individuals with diabetes and expanding the market by attracting more patients to pharmacological treatments.

South Korea Diabetes Drugs Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on drugs and distribution channel.

Drugs Insights:

  • Insulins
    • Basal or Long Acting Insulins
    • Bolus or Fast Acting Insulins
    • Traditional Human Insulins
    • Biosimilar Insulins
  • Oral Anti-diabetic Drugs
    • Biguanides
    • Alpha-Glucosidase Inhibitors
    • Dopamine D2 Receptor Agonist
    • SGLT-2 Inhibitors
    • DPP-4 Inhibitors
    • Sulfonylureas
    • Meglitinides
  • Non-Insulin Injectable Drugs
    • GLP-1 Receptor Agonists
    • Amylin Analogue
  • Combination Drugs
    • Insulin Combinations
    • Oral Combinations
       

The report has provided a detailed breakup and analysis of the market based on the drugs. This includes insulins (basal or long acting insulins, bolus or fast acting insulins, traditional human insulins, and biosimilar insulins), oral anti-diabetic drugs (biguanides, alpha-glucosidase inhibitors, dopamine D2 receptor agonist, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas, and meglitinides), non-insulin injectable drugs (GLP-1 receptor agonists and amylin analogue), and combination drugs (insulin combinations and oral combinations).

Distribution Channel Insights:

  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
     

A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes online pharmacies, hospital pharmacies, and retail pharmacies.

Regional Insights:

  • Seoul Capital Area
  • Yeongnam (Southeastern Region)
  • Honam (Southwestern Region)
  • Hoseo (Central Region)
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

South Korea Diabetes Drugs Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: 
  • Drugs
  • Distribution Channel
  • Region
Drugs Covered
  • Insulins: Basal or Long Acting Insulins, Bolus or Fast Acting Insulins, Traditional Human Insulins, Biosimilar Insulin
  • Oral Anti-diabetic Drugs: Biguanides, Alpha-Glucosidase Inhibitors, Dopamine D2 Receptor Agonist, SGLT-2 Inhibitors, DPP-4 Inhibitors, Sulfonylureas, Meglitinides
  • Non-Insulin Injectable Drugs: GLP-1 Receptor Agonists, Amylin Analogue
  • Combination Drugs: Insulin Combinations, Oral Combinations
Distribution Channels Covered Online Pharmacies, Hospital Pharmacies, Retail Pharmacies
Regions Covered Seoul Capital Area, Yeongnam (Southeastern Region), Honam (Southwestern Region), Hoseo (Central Region), Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the South Korea diabetes drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the South Korea diabetes drugs market?
  • What is the breakup of the South Korea diabetes drugs market on the basis of drugs?
  • What is the breakup of the South Korea diabetes drugs market on the basis of distribution channel?
  • What are the various stages in the value chain of the South Korea diabetes drugs market? 
  • What are the key driving factors and challenges in the South Korea diabetes drugs?
  • What is the structure of the South Korea diabetes drugs market and who are the key players?
  • What is the degree of competition in the South Korea diabetes drugs market?

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the South Korea diabetes drugs market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the South Korea diabetes drugs market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the South Korea diabetes drugs industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More